Subscribe

Xeris Biopharma Holdings, Inc. (XERS)

USD8.56 +0.28 (+3.32%)
US NASDAQ Healthcare Biotechnology
Address 180 North LaSalle Street 60601
Chicago, IL, US
CEO John Shannon
IPO 2018-06-21
CIK 1867096 ISIN US98422E1038

Explore sections of this company profile

Also trades on London Stock Exchange · 0A8E.L (USD) NASDAQ Global Select · XERS (USD)
Description

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypokalemic, and related forms of primary periodic paralysis. Recorlev: A cortisol synthesis inhibitor approved for managing endogenous hypercortisolemia in adult patients with Cushing's syndrome. Beyond its marketed products, the company maintains an active development pipeline. This pipeline seeks to broaden the applications and indications for existing treatments and introduce novel pharmaceuticals leveraging its proprietary XeriSol and XeriJect formulation technology platforms. Founded in 2005, Xeris Biopharma is headquartered in Chicago, Illinois.

News Sentiment (7d)
59 Neutral

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Date Filing
COMPUTERSHARE 2021-07-02 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD8.56 +0.28 (+3.32%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.90
Float Shares
160.57M
Free Float %
93.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-5.97% -8.36% +4.96% -11.14% -19.10% -21.78% +24.04% +111.72% +84.38% -69.63% -69.63%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (10 ratings, all time) Buy
Price Targets & DCF
Current price
8.56
Low 9.00 +5.2%
Consensus 9.00 +5.2%
Median 9.00 +5.2%
High 9.00 +5.2%
Ratings Trend (MoM) 86% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 5 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year 2
13.50
+57.8%
All Time 7
7.44
-13.0%
Quality scores
Altman Z-Score
0.77
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
4 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    +43.7% Q1'26: +38.3% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    +100.9% Q1'26: +120.8% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -9.4% Q1'26: +11.5% (vs Q1'25)
  • EBIT margin Biotechnology: +0.0%
    +0.2% Q1'26: +9.5% (vs Q1'25)
  • ROIC Biotechnology: -16.1%
    Q1'26: -51.6% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +17.7% Q1'26: +16.5% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    2.97× Q1'26: 0.84× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.92) × ERP
WACC = 97% × Ke + 3% × Kd (77.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 8.56
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
5 Rev. Ana.
3 EPS Ana.
Dec 2027
5 Rev. Ana.
4 EPS Ana.
Dec 2028
6 Rev. Ana.
4 EPS Ana.
Dec 2029
5 Rev. Ana.
2 EPS Ana.
Dec 2030
3 Rev. Ana.
2 EPS Ana.
Revenue
2.47M
est: 1.86M (+32.8%)
2.72M
est: 1.50M (+81.3%)
20.44M
est: 22.03M (-7.2%)
49.59M
est: 47.47M (+4.5%)
110.25M
est: 107.94M (+2.1%)
163.91M
est: 181.41M (-9.6%)
203.07M
est: 201.08M (+1.0%)
291.85M
est: 288.22M (+1.3%)
385.85M
384.51M – 386.83M
+33.9% YoY
473.55M
460.65M – 489.43M
+22.7% YoY
542.67M
540.89M – 544.44M
+14.6% YoY
623.67M
609.50M – 638.52M
+14.9% YoY
704.45M
688.44M – 721.23M
+13.0% YoY
EBITDA
-57.22M
est: -1.05M (-5,323.4%)
-117.80M
est: -853.4K (-13,703.1%)
-79.12M
est: -12.52M (-531.8%)
-113.67M
est: -26.99M (-321.2%)
-69.31M
est: -61.36M (-13.0%)
-23.74M
est: -65.27M (+63.6%)
-13.99M
est: -72.34M (+80.7%)
12.71M
est: -103.70M (+112.3%)
-138.82M
-139.17M – -138.34M
-33.9% YoY
-170.37M
-176.08M – -165.73M
-22.7% YoY
-195.24M
-195.88M – -194.60M
-14.6% YoY
-224.38M
-229.72M – -219.28M
-14.9% YoY
-253.44M
-259.48M – -247.68M
-13.0% YoY
EBIT
-57.54M
est: -1.15M (-4,900.9%)
-118.88M
est: -930.7K (-12,672.9%)
-80.59M
est: -13.66M (-490.0%)
-115.55M
est: -29.43M (-292.6%)
-81.98M
est: -66.92M (-22.5%)
-36.90M
est: -76.12M (+51.5%)
-26.62M
est: -84.37M (+68.4%)
554.0K
est: -120.93M (+100.5%)
-161.89M
-162.30M – -161.33M
-33.9% YoY
-198.69M
-205.35M – -193.28M
-22.7% YoY
-227.69M
-228.44M – -226.95M
-14.6% YoY
-261.68M
-267.91M – -255.73M
-14.9% YoY
-295.57M
-302.61M – -288.86M
-13.0% YoY
Net Income
-60.08M
est: -818.63M (+92.7%)
-125.58M
est: -691.89M (+81.8%)
-91.14M
est: -314.09M (+71.0%)
-122.73M
est: -178.77M (+31.4%)
-94.66M
est: -102.52M (+7.7%)
-62.26M
est: -72.90M (+14.6%)
-54.84M
est: -62.79M (+12.7%)
554.0K
est: -2.54M (+121.8%)
21.50M
11.48M – 36.34M
+945.4% YoY
65.90M
27.55M – 74.55M
+206.5% YoY
112.53M
60.72M – 131.56M
+70.8% YoY
162.95M
158.14M – 168.00M
+44.8% YoY
193.47M
187.76M – 199.46M
+18.7% YoY
SGA
21.11M
est: 3.37M (+525.9%)
63.06M
est: 2.73M (+2,210.9%)
73.73M
est: 40.05M (+84.1%)
125.72M
est: 86.29M (+45.7%)
137.75M
est: 196.21M (-29.8%)
146.10M
est: 221.53M (-34.1%)
163.48M
est: 245.55M (-33.4%)
182.37M
est: 351.97M (-48.2%)
471.18M
469.55M – 472.38M
+33.9% YoY
578.28M
562.53M – 597.67M
+22.7% YoY
662.68M
660.51M – 664.85M
+14.6% YoY
761.60M
744.29M – 779.73M
+14.9% YoY
860.24M
840.70M – 880.73M
+13.0% YoY
EPS
-4.99
est: -5.58 (+10.5%)
-3.49
est: -4.71 (+26.0%)
-2.14
est: -2.14 (+0.0%)
-1.55
est: -1.22 (-27.3%)
-0.70
est: -0.67 (-3.8%)
-0.45
est: -0.42 (-6.7%)
-0.37
est: -0.36 (-3.0%)
0.00
est: -0.02 (+115.8%)
0.13
0.07 – 0.21
+701.6% YoY
0.35
0.16 – 0.43
+161.3% YoY
0.59
0.35 – 0.76
+69.5% YoY
0.94
0.92 – 0.97
+60.4% YoY
1.12
1.09 – 1.15
+18.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-07 C+ 2/5 1/5 5/5 4/5 1/5 1/5 1/5
2026-05-06 C 2/5 1/5 3/5 3/5 1/5 1/5 1/5
2026-05-05 C 2/5 1/5 3/5 3/5 1/5 1/5 1/5
2026-05-04 C 2/5 1/5 3/5 3/5 1/5 1/5 1/5
2026-05-01 C- 1/5 1/5 2/5 3/5 1/5 1/5 1/5
2026-04-30 C- 1/5 1/5 2/5 3/5 1/5 1/5 1/5
2026-04-29 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-28 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-27 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-24 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-23 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-22 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-21 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-20 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-17 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5
2026-04-16 C 2/5 1/5 2/5 4/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
60.14M
OE per share TTM
0.34
Owner's Yield
5.32%
Maintenance CapEx ratio
126.31%
Maint CapEx / Avg PPE
13.7%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
47
Total invested
24.87M
Insider transactions (90d)
1
Beneficial owners (>5%)
26
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Deerfield Management Company, L.P. 12.44M 9.88% 12.44M PN Delaware 2021-03-17
2 James E. Flynn 12.44M 9.88% 12.44M IN Delaware 2021-03-17
3 (1) BlackRock, Inc. 10.01M 7.20% 9.93M 10.01M HC Delaware 2024-01-26
4 (1)Names of reporting persons. BlackRock, Inc. 8.58M 6.30% 8.46M 8.58M HC Delaware 2023-02-10
5 Bruce S. Kovner 7.83M 5.70% 7.83M 7.83M IN Delaware 2022-01-05
6 Caxton Corporation 7.83M 5.70% 7.83M 7.83M CO Delaware 2022-01-05
7 CDK Associates, L.L.C. 7.76M 5.70% 7.76M 7.76M OO Delaware 2022-01-05
8 The Vanguard Group - 23-1945930 7.09M 5.13% 6.82M 264.5K IA Pennsylvania 2024-02-13
9 Deerfield Mgmt III, L.P. 6.91M 5.49% 6.91M PN Delaware 2021-03-17
10 Deerfield Private Design Fund III, L.P. 6.91M 5.49% 6.91M PN Delaware 2021-03-17
11 Jon M. Plexico 6.49M 11.00% 6.49M 6.49M HC, IN California 2022-01-14
12 Stonepine Capital Management, LLC 6.49M 11.00% 6.49M 6.49M IA, OO California 2022-01-14
13 Stonepine Capital, L.P. 6.49M 11.00% 6.49M 6.49M PN California 2022-01-14
14 Timothy P. Lynch 6.49M 11.00% 6.49M 6.49M HC, IN California 2022-01-14
15 Company, L.P. 5.88M 4.99% 5.88M PN 2021-02-12
16 Deerfield Mgmt, L.P. 5.53M 4.99% 5.53M PN Delaware 2021-03-17
17 Deerfield Partners, L.P. 5.53M 4.99% 5.53M PN Delaware 2021-03-17
18 John Petry 3.26M 2.40% 3.26M 3.26M IN Cayman Islands 2022-02-14
19 Sessa Capital (Master), L.P. 3.26M 2.40% 3.26M 3.26M PN Cayman Islands 2022-02-14
20 Sessa Capital GP, LLC 3.26M 2.40% 3.26M 3.26M OO Cayman Islands 2022-02-14
21 Sessa Capital IM GP, LLC 3.26M 2.40% 3.26M 3.26M OO Cayman Islands 2022-02-14
22 Sessa Capital IM, L.P. 3.26M 2.40% 3.26M 3.26M PN Cayman Islands 2022-02-14
23 ArrowMark Colorado Holdings, LLC 1.98M 3.30% 1.98M 1.98M IA Delaware, United States 2021-02-16
24 Deerfield Special Situations Fund, L.P. 0.00% PN 2021-02-12
25 GEORGE SOROS 0.00% IN 2021-02-11
26 SOROS FUND MANAGEMENT LLC 0.00% OO Delaware 2021-02-11

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
47
-185 vs prev Q
New positions
5
Closed positions
184
Increased
23
Reduced
9
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 800.0K +800.0K (+100.0%) 6.28B +6.3B (+100.0%) 0.45% +0.450 pp 7.18% +7.181 pp USD7.85 +0.0% 1 qtrs NEW
2 BLACKROCK, INC. 12.64M +711.6K (+6.0%) 99.22M +2.1M (+2.2%) 7.12% -0.531 pp 0.00% +0.000 pp USD3.41 +130.2% 6 qtrs
3 VANGUARD GROUP INC 11.19M +1.4M (+13.8%) 87.82M +7.8M (+9.8%) 6.30% -0.003 pp 0.00% +0.000 pp USD3.59 +118.7% 17 qtrs
4 D. E. SHAW & CO., INC. 7.57M +1.7M (+29.7%) 59.46M +11.9M (+25.1%) 4.26% +0.521 pp 0.03% +0.006 pp USD6.17 +27.2% 16 qtrs
5 GEODE CAPITAL MANAGEMENT, LLC 4.28M +135.8K (+3.3%) 33.57M -136.6K (-0.4%) 2.41% -0.247 pp 0.00% 0.000 pp USD3.16 +148.4% 18 qtrs
6 STATE STREET CORP 4.12M +378.6K (+10.1%) 32.32M +1.9M (+6.2%) 2.32% -0.079 pp 0.00% +0.000 pp USD2.82 +178.4% 17 qtrs
7 QUBE RESEARCH & TECHNOLOGIES LTD 3.50M +223.4K (+6.8%) 27.46M +803.7K (+3.0%) 1.97% -0.130 pp 0.03% +0.000 pp USD5.17 +51.8% 10 qtrs
8 DRIEHAUS CAPITAL MANAGEMENT LLC 2.98M +361.4K (+13.8%) 23.40M +2.1M (+9.7%) 1.68% -0.001 pp 0.16% +0.006 pp USD5.66 +38.7% 5 qtrs
9 NUVEEN, LLC 2.81M -21.1K (-0.7%) 22.03M -985.5K (-4.3%) 1.58% -0.233 pp 0.01% 0.000 pp USD5.60 +40.2% 4 qtrs
10 MORGAN STANLEY 2.71M -511.9K (-15.9%) 21.26M -5.0M (-18.9%) 1.52% -0.540 pp 0.00% 0.000 pp USD3.57 +119.9% 17 qtrs
11 WELLINGTON MANAGEMENT GROUP LLP 2.29M +1.7M (+293.6%) 17.95M +13.2M (+279.6%) 1.29% +0.915 pp 0.00% +0.002 pp USD6.90 +13.8% 8 qtrs
12 ROSALIND ADVISORS, INC. 2.11M +315.9K (+17.6%) 16.58M +2.0M (+13.4%) 1.19% +0.038 pp 5.83% +0.830 pp USD3.16 +148.4% 9 qtrs
13 TWO SIGMA INVESTMENTS, LP 1.73M +118.1K (+7.3%) 13.60M +458.8K (+3.5%) 0.98% -0.060 pp 0.02% 0.000 pp USD6.11 +28.5% 4 qtrs
14 PARKMAN HEALTHCARE PARTNERS LLC 1.69M -100.1K (-5.6%) 13.28M -1.3M (-9.0%) 0.95% -0.196 pp 1.26% -0.257 pp USD4.73 +66.0% 8 qtrs
15 GOLDMAN SACHS GROUP INC 1.57M -227.0K (-12.6%) 12.31M -2.3M (-15.8%) 0.88% -0.268 pp 0.00% 0.000 pp USD4.07 +92.9% 17 qtrs
16 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.40M -42.8K (-3.0%) 11.02M -755.5K (-6.4%) 0.79% -0.137 pp 0.00% 0.000 pp USD5.98 +31.3% 17 qtrs
17 LEGAL & GENERAL GROUP PLC 1.40M +38.8K (+2.9%) 10.95M -95.2K (-0.9%) 0.79% -0.084 pp 0.00% +0.000 pp USD5.05 +55.4% 15 qtrs
18 CENTERBOOK PARTNERS LP 1.39M +693.4K (+99.3%) 10.92M +5.2M (+92.2%) 0.78% +0.336 pp 0.53% +0.253 pp USD5.94 +32.2% 9 qtrs
19 NORTHERN TRUST CORP 1.39M +23.7K (+1.7%) 10.89M -209.3K (-1.9%) 0.78% -0.093 pp 0.00% +0.000 pp USD2.53 +210.3% 17 qtrs
20 GRANAHAN INVESTMENT MANAGEMENT, LLC 1.22M +873.2K (+249.4%) 9.60M +6.8M (+236.9%) 0.69% +0.464 pp 0.41% +0.295 pp USD7.93 -1.0% 2 qtrs
21 KENNEDY CAPITAL MANAGEMENT LLC 1.21M +2.4K (+0.2%) 9.53M -332.6K (-3.4%) 0.68% -0.093 pp 0.20% -0.016 pp USD4.88 +60.9% 6 qtrs
22 CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 1.06M -640.1K (-37.7%) 8.31M -5.5M (-39.9%) 0.60% -0.493 pp 0.02% -0.022 pp USD5.68 +38.2% 6 qtrs
23 ACADIAN ASSET MANAGEMENT LLC 971.6K +50.5K (+5.5%) 7.62M +126.0K (+1.7%) 0.55% -0.044 pp 0.01% -0.001 pp USD6.77 +16.0% 4 qtrs
24 KNOTT DAVID M JR 970.0K -45.0K (-4.4%) 7.61M -647.6K (-7.8%) 0.55% -0.105 pp 3.53% +0.194 pp USD2.67 +194.0% 9 qtrs
25 AQR CAPITAL MANAGEMENT LLC 957.6K -26.0K (-2.6%) 7.52M -489.5K (-6.1%) 0.54% -0.092 pp 0.00% -0.001 pp USD2.77 +183.4% 14 qtrs
26 DEUTSCHE BANK AG\ 940.6K -627.1K (-40.0%) 7.38M -5.4M (-42.1%) 0.53% -0.476 pp 0.00% -0.002 pp USD6.66 +17.9% 15 qtrs
27 JPMORGAN CHASE & CO 895.1K -10.0K (-1.1%) 7.03M -341.1K (-4.6%) 0.50% -0.076 pp 0.00% +0.000 pp USD4.24 +85.1% 17 qtrs
28 MILLENNIUM MANAGEMENT LLC 859.1K +334.3K (+63.7%) 6.74M +2.5M (+57.9%) 0.48% +0.147 pp 0.00% +0.001 pp USD5.16 +52.1% 17 qtrs
29 FEDERATED HERMES, INC. 854.9K +150.5K (+21.4%) 6.71M +977.2K (+17.0%) 0.48% +0.030 pp 0.01% +0.001 pp USD5.94 +32.2% 6 qtrs
30 TWO SIGMA ADVISERS, LP 849.3K -43.9K (-4.9%) 6.67M -603.7K (-8.3%) 0.48% -0.095 pp 0.01% -0.002 pp USD5.36 +46.5% 8 qtrs
31 VOLORIDGE INVESTMENT MANAGEMENT, LLC 811.1K -223.4K (-21.6%) 6.37M -2.1M (-24.4%) 0.46% -0.207 pp 0.02% -0.006 pp USD5.59 +40.4% 4 qtrs
32 NORGES BANK 800.7K +800.7K (+100.0%) 6.29M +6.3M (+100.0%) 0.45% +0.451 pp 0.00% +0.001 pp USD7.85 +0.0% 1 qtrs NEW
33 ESSEX INVESTMENT MANAGEMENT CO LLC 734.5K -15.5K (-2.1%) 5.77M -339.2K (-5.6%) 0.41% -0.067 pp 0.88% -0.055 pp USD4.25 +84.7% 5 qtrs
34 ALGERT GLOBAL LLC 718.8K +560.9K (+355.1%) 5.64M +4.4M (+338.8%) 0.40% +0.303 pp 0.09% +0.067 pp USD7.91 -0.8% 2 qtrs
35 BANK OF AMERICA CORP /DE/ 717.9K -877.0K (-55.0%) 5.64M -7.3M (-56.6%) 0.40% -0.618 pp 0.00% -0.001 pp USD3.71 +111.6% 17 qtrs
36 UBS ASSET MANAGEMENT AMERICAS INC 651.4K +468.0K (+255.1%) 5.11M +3.6M (+242.4%) 0.37% +0.249 pp 0.00% +0.001 pp USD7.73 +1.6% 3 qtrs
37 RENAISSANCE TECHNOLOGIES LLC 619.7K -1.0M (-61.8%) 4.86M -8.3M (-63.2%) 0.35% -0.692 pp 0.01% -0.010 pp USD2.78 +182.4% 17 qtrs
38 PRUDENTIAL FINANCIAL INC 618.9K -815.3K (-56.8%) 4.86M -6.8M (-58.4%) 0.35% -0.571 pp 0.01% -0.008 pp USD5.19 +51.3% 11 qtrs
39 POINT72 ASSET MANAGEMENT, L.P. 608.1K +608.1K (+100.0%) 4.77M +4.8M (+100.0%) 0.34% +0.342 pp 0.01% +0.005 pp USD7.85 +0.0% 4 qtrs
40 UBS GROUP AG 601.8K -1.2M (-66.2%) 4.72M -9.8M (-67.4%) 0.34% -0.804 pp 0.00% -0.002 pp USD7.51 +4.5% 17 qtrs
41 HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 537.5K +283.5K (+111.6%) 4.22M +2.2M (+104.1%) 0.30% +0.140 pp 0.01% +0.003 pp USD6.74 +16.5% 4 qtrs
42 SQUAREPOINT OPS LLC 482.8K -196.2K (-28.9%) 3.79M -1.7M (-31.4%) 0.27% -0.164 pp 0.00% -0.002 pp USD6.65 +18.0% 6 qtrs
43 VOYA INVESTMENT MANAGEMENT LLC 458.3K +58.3K (+14.6%) 3.60M +341.2K (+10.5%) 0.26% +0.002 pp 0.00% +0.000 pp USD7.53 +4.2% 15 qtrs
44 CASTLEARK MANAGEMENT LLC 446.0K +446.0K (+100.0%) 3.50M +3.5M (+100.0%) 0.25% +0.251 pp 0.10% +0.103 pp USD7.85 +0.0% 1 qtrs NEW
45 FMR LLC 439.7K +79.5K (+22.1%) 3.45M +519.8K (+17.7%) 0.25% +0.017 pp 0.00% +0.000 pp USD5.80 +35.3% 16 qtrs
46 BANK OF NEW YORK MELLON CORP 434.3K -5.6K (-1.3%) 3.41M -171.3K (-4.8%) 0.24% -0.038 pp 0.00% 0.000 pp USD3.24 +142.3% 17 qtrs
47 CITADEL ADVISORS LLC 409.8K -27.8K (-6.4%) 3.22M -345.1K (-9.7%) 0.23% -0.050 pp 0.00% 0.000 pp USD8.14 -3.6% 5 qtrs
48 SEI INVESTMENTS CO 399.3K +278.2K (+229.6%) 3.13M +2.1M (+217.8%) 0.22% +0.147 pp 0.00% +0.002 pp USD7.13 +10.1% 4 qtrs
49 CANADA PENSION PLAN INVESTMENT BOARD 390.6K +14.9K (+4.0%) 3.07M +8.0K (+0.3%) 0.22% -0.021 pp 0.00% 0.000 pp USD8.13 -3.4% 2 qtrs
50 VOSS CAPITAL, LLC 371.7K +51.9K (+16.2%) 2.92M +1.4M (+95.4%) 0.21% +0.004 pp 0.14% +0.068 pp USD5.72 +37.2% 4 qtrs
51 RUSSELL INVESTMENTS GROUP, LTD. 364.8K +113.4K (+45.1%) 2.86M +817.4K (+39.9%) 0.21% +0.044 pp 0.00% +0.001 pp USD7.06 +11.2% 10 qtrs
52 BARCLAYS PLC 362.8K +38.3K (+11.8%) 2.85M +1.9M (+207.9%) 0.20% -0.004 pp 0.00% +0.000 pp USD3.73 +110.5% 16 qtrs
53 STATE OF WISCONSIN INVESTMENT BOARD 357.5K +6.9K (+2.0%) 2.81M -47.3K (-1.7%) 0.20% -0.024 pp 0.01% 0.000 pp USD5.48 +43.2% 4 qtrs
54 JUMP FINANCIAL, LLC 341.1K -262.2K (-43.5%) 2.68M -2.2M (-45.5%) 0.19% -0.195 pp 0.03% -0.026 pp USD5.05 +55.4% 5 qtrs
55 HRT FINANCIAL LP 332.3K +259.8K (+358.1%) 2.61M +2.0M (+342.0%) 0.19% +0.141 pp 0.01% +0.006 pp USD7.91 -0.8% 5 qtrs
56 SWISS NATIONAL BANK 318.4K +8.0K (+2.6%) 2.50M -27.2K (-1.1%) 0.18% -0.020 pp 0.00% +0.000 pp USD8.13 -3.4% 2 qtrs
57 HARVEST INVESTMENT SERVICES, LLC 292.7K -32.9K (-10.1%) 2.30M -352.5K (-13.3%) 0.16% -0.044 pp 0.43% -0.100 pp USD7.06 +11.2% 4 qtrs
58 IHT WEALTH MANAGEMENT, LLC 263.5K +5.4K (+2.1%) 2.07M -32.8K (-1.6%) 0.15% -0.017 pp 0.05% -0.003 pp USD1.72 +356.4% 17 qtrs
59 BNP PARIBAS ARBITRAGE, SNC 258.4K -323.4K (-55.6%) 2.03M -2.7M (-57.2%) 0.15% -0.228 pp 0.00% -0.002 pp USD8.05 -2.5% 5 qtrs
60 APELLA CAPITAL, LLC 245.9K +235.9K (+2,359.0%) 1.93M +1.8M (+2,011.9%) 0.14% +0.132 pp 0.04% +0.036 pp USD7.75 +1.3% 4 qtrs
61 LEGATO CAPITAL MANAGEMENT LLC 237.4K +20.6K (+9.5%) 1.86M +99.0K (+5.6%) 0.13% -0.005 pp 0.16% -0.032 pp USD4.44 +76.8% 5 qtrs
62 SCHONFELD STRATEGIC ADVISORS LLC 234.7K -69.8K (-22.9%) 1.84M -636.1K (-25.7%) 0.13% -0.063 pp 0.01% -0.006 pp USD4.92 +59.6% 8 qtrs
63 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 214.8K +214.8K (+100.0%) 1.69M +1.7M (+100.0%) 0.12% +0.121 pp 0.00% +0.001 pp USD7.85 +0.0% 1 qtrs NEW
64 TREXQUANT INVESTMENT LP 213.6K -15.8K (-6.9%) 1.68M -190.9K (-10.2%) 0.12% -0.027 pp 0.01% -0.004 pp USD8.14 -3.6% 2 qtrs
65 RAYMOND JAMES FINANCIAL INC 211.4K +6.2K (+3.0%) 1.66M -10.8K (-0.6%) 0.12% -0.013 pp 0.00% +0.000 pp USD5.32 +47.6% 5 qtrs
66 COMMONWEALTH EQUITY SERVICES, LLC 197.8K +72.0 (+0.0%) 1.55M -57.2K (-3.5%) 0.11% -0.015 pp 0.00% +0.000 pp USD2.32 +238.4% 8 qtrs
67 RHUMBLINE ADVISERS 189.6K -24.2K (-11.3%) 1.49M -251.8K (-14.5%) 0.11% -0.030 pp 0.00% 0.000 pp USD2.20 +256.8% 15 qtrs
68 JANE STREET GROUP, LLC 177.8K -735.9K (-80.5%) 1.40M -6.0M (-81.2%) 0.10% -0.486 pp 0.00% -0.001 pp USD8.01 -2.0% 17 qtrs
69 CAXTON ASSOCIATES LLP 174.1K -107.2K (-38.1%) 1.37M -923.4K (-40.3%) 0.10% -0.082 pp 0.03% -0.027 pp USD8.14 -3.6% 4 qtrs
70 PRICE T ROWE ASSOCIATES INC /MD/ 173.5K +6.7K (+4.0%) 1.36M +4.0K (+0.3%) 0.10% -0.009 pp 0.00% +0.000 pp USD2.88 +172.6% 17 qtrs
71 WELLS FARGO & COMPANY/MN 170.8K +73.6K (+75.7%) 1.34M +549.6K (+69.5%) 0.10% +0.034 pp 0.00% +0.000 pp USD5.52 +42.2% 17 qtrs
72 DIADEMA PARTNERS LP 170.6K +95.8K (+128.2%) 1.34M +730.5K (+120.0%) 0.10% +0.048 pp 0.23% +0.075 pp USD7.98 -1.6% 2 qtrs
73 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 151.2K -715.0 (-0.5%) 1.19M -49.7K (-4.0%) 0.09% -0.012 pp 0.00% 0.000 pp USD7.70 +1.9% 15 qtrs
74 PRINCIPAL FINANCIAL GROUP INC 150.6K +45.1K (+42.7%) 1.18M +323.2K (+37.6%) 0.08% +0.017 pp 0.00% +0.000 pp USD4.48 +75.2% 15 qtrs
75 ALLIANCEBERNSTEIN L.P. 144.8K +— (+0.0%) 1.14M -42.0K (-3.6%) 0.08% -0.011 pp 0.00% +0.000 pp USD2.37 +231.2% 15 qtrs
76 AMERIPRISE FINANCIAL INC 143.5K -10.7K (-6.9%) 1.13M -128.7K (-10.3%) 0.08% -0.018 pp 0.00% +0.000 pp USD2.44 +221.7% 17 qtrs
77 POLEN CAPITAL MANAGEMENT LLC 133.4K +225.0 (+0.2%) 1.05M -36.9K (-3.4%) 0.08% -0.010 pp 0.00% +0.001 pp USD4.68 +67.7% 3 qtrs
78 GROUP ONE TRADING, L.P. 123.6K +117.5K (+1,951.1%) 970.0K +920.9K (+1,878.1%) 0.07% +0.066 pp 0.00% +0.002 pp USD7.86 -0.1% 2 qtrs
79 CAPTION MANAGEMENT, LLC 123.4K +123.4K (+100.0%) 968.7K +968.7K (+100.0%) 0.07% +0.070 pp 0.01% +0.007 pp USD7.85 +0.0% 1 qtrs NEW
80 GLOBEFLEX CAPITAL L P 123.2K +— (+0.0%) 967.0K -35.7K (-3.6%) 0.07% -0.010 pp 0.15% -0.006 pp USD5.04 +55.8% 5 qtrs
81 FRANKLIN RESOURCES INC 121.4K +12.3K (+11.3%) 953.2K +64.8K (+7.3%) 0.07% -0.002 pp 0.00% +0.000 pp USD5.35 +46.7% 7 qtrs
82 SUSQUEHANNA INTERNATIONAL GROUP, LLP 117.4K +35.9K (+44.0%) 921.2K +258.1K (+38.9%) 0.07% +0.014 pp 0.00% +0.000 pp USD5.89 +33.3% 17 qtrs
83 CREATIVE PLANNING 116.5K -10.4K (-8.2%) 914.8K -118.8K (-11.5%) 0.07% -0.016 pp 0.00% 0.000 pp USD3.67 +113.9% 8 qtrs
84 INVESCO LTD. 112.1K -471.0K (-80.8%) 880.2K -3.9M (-81.5%) 0.06% -0.311 pp 0.00% -0.001 pp USD7.72 +1.7% 17 qtrs
85 SG AMERICAS SECURITIES, LLC 110.2K +27.0K (+32.4%) 865.0K +188.0K (+27.8%) 0.06% +0.009 pp 0.00% -0.001 pp USD7.15 +9.8% 14 qtrs
86 AMBASSADOR ADVISORS, LLC 106.7K +106.7K (+100.0%) 837.8K +837.8K (+100.0%) 0.06% +0.060 pp 0.12% +0.123 pp USD7.85 +0.0% 1 qtrs NEW
87 THOMPSON SIEGEL & WALMSLEY LLC 100.9K +— (+0.0%) 792.0K -29.0K (-3.5%) 0.06% -0.008 pp 0.01% +0.000 pp USD3.28 +139.3% 8 qtrs
88 RESOLUTE CAPITAL ASSET PARTNERS LLC 100.0K +100.0K (+100.0%) 785.0K +785.0K (+100.0%) 0.06% +0.056 pp 0.38% +0.379 pp USD7.85 +0.0% 1 qtrs NEW
89 CALAMOS ADVISORS LLC 99.1K -38.0K (-27.7%) 778.1K -337.9K (-30.3%) 0.06% -0.032 pp 0.00% -0.001 pp USD8.14 -3.6% 2 qtrs
90 CITIGROUP INC 98.7K +28.5K (+40.6%) 775.2K +203.3K (+35.5%) 0.06% +0.011 pp 0.00% +0.000 pp USD4.19 +87.4% 17 qtrs
91 ROUND ROCK ADVISORS, LLC 96.8K +33.0K (+51.8%) 760.0K +177.8K (+30.5%) 0.05% +0.014 pp 0.11% +0.022 pp USD8.04 -2.4% 2 qtrs
92 BREVAN HOWARD CAPITAL MANAGEMENT LP 92.4K -39.7K (-30.1%) 725.5K -350.3K (-32.6%) 0.05% -0.033 pp 0.01% +0.003 pp USD5.44 +44.3% 4 qtrs
93 Y-INTERCEPT (HONG KONG) LTD 90.6K +8.5K (+10.3%) 711.6K +42.6K (+6.4%) 0.05% -0.002 pp 0.02% 0.000 pp USD5.07 +54.8% 4 qtrs
94 ENGINEERS GATE MANAGER LP 89.4K -20.6K (-18.7%) 701.8K -193.5K (-21.6%) 0.05% -0.020 pp 0.01% -0.002 pp USD6.94 +13.1% 3 qtrs
95 JEFFERIES FINANCIAL GROUP INC. 87.8K +87.8K (+100.0%) 689.2K +689.2K (+100.0%) 0.05% +0.049 pp 0.00% +0.004 pp USD7.85 +0.0% 1 qtrs NEW
96 IEQ CAPITAL, LLC 86.5K -21.4K (-19.9%) 679.2K -199.6K (-22.7%) 0.05% -0.021 pp 0.00% -0.001 pp USD4.39 +78.8% 17 qtrs
97 LPL FINANCIAL LLC 84.9K +51.6K (+154.8%) 666.2K +395.1K (+145.7%) 0.05% +0.026 pp 0.00% +0.000 pp USD5.80 +35.3% 9 qtrs
98 EAM INVESTORS, LLC 80.2K -522.9K (-86.7%) 629.2K -4.2M (-87.0%) 0.05% -0.342 pp 0.07% -0.486 pp USD5.08 +54.5% 5 qtrs
99 QUARRY LP 80.0K -2.5K (-3.0%) 628.0K -43.6K (-6.5%) 0.05% -0.008 pp 0.10% -0.049 pp USD5.03 +56.1% 4 qtrs
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 97 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Virtus Biotech ETF BBP 1.58% 1.56M 0.34%
2 State Street SPDR S&P Pharmaceuticals ETF XPH 1.44% 6.78M 0.35%
3 Janus Henderson Small Cap Growth Alpha ETF JSML 0.74% 2.74M 0.30%
4 KraneShares Man Buyout Beta Index ETF BUYO 0.54% 89.0K 0.89%
5 Janus Henderson Small/Mid Cap Growth Alpha ETF JSMD 0.49% 5.25M 0.30%
6 iShares U.S. Pharmaceuticals ETF IHE 0.32% 4.35M 0.38%
7 iShares Micro-Cap ETF IWC 0.32% 4.79M 0.60%
8 Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL 0.30% 69.7K 1.22%
9 First Trust Small Cap Core AlphaDEX Fund FYX 0.20% 2.74M 0.58%
10 First Trust Multi Cap Growth AlphaDEX Fund FAD 0.11% 627.0K 0.63%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
Shares disposed
33.3K
Cash buys
Cash sales
2.00
Net activity
-33,334
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-01 Hecht Beth Officer S-Sale D Common Stock 16,667 6.23 103.8K 1,193,173 D
2026-04-01 Hecht Beth Officer S-Sale D Common Stock 16,667 5.99 99.9K 1,209,840 D
2026-03-30 Brady James Aloysius Director S-Sale D Common Stock 10,834 5.54 60.0K 89,166 D
2026-03-12 McCulloch Kevin Officer M-Exempt A Common Stock 4 3.94 15.76 1,777,725 D
2026-03-05 Pieper Steven Officer M-Exempt A Common Stock 14,036 5.93 83.2K 1,408,940 D
2026-03-02 Hecht Beth Officer S-Sale D Common Stock 16,567 6.24 103.4K 1,226,607 D
2026-02-24 Nguyen Anh Tu Officer F-InKind D Common Stock 29,300 6.88 201.6K 395,023 D
2026-02-02 Hecht Beth Officer S-Sale D Common Stock 16,667 7.45 124.1K 1,243,174 D
2026-01-31 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 118,134 7.36 869.5K 3,157,949 D
2026-01-31 Pieper Steven Officer F-InKind D Common Stock 66,450 7.36 489.1K 1,394,332 D
2026-01-31 McCulloch Kevin Officer F-InKind D Common Stock 68,454 7.36 503.8K 1,785,435 D
2026-01-31 Hecht Beth Officer F-InKind D Common Stock 24,266 7.36 178.6K 1,259,841 D
2026-01-30 Shannon John Patrick Jr Director / Officer A-Award A Stock Option (Right to Buy) 639,639 7.36 4.71M 639,639 D
2026-01-30 Pieper Steven Officer A-Award A Common Stock 154,986 0.00 1,572,547 D
2026-01-30 Nguyen Anh Tu Officer A-Award A Stock Option (Right to Buy) 162,162 7.36 1.19M 162,162 D
2026-01-30 McCulloch Kevin Officer A-Award A Stock Option (Right to Buy) 225,225 7.36 1.66M 225,225 D
2026-01-30 Hecht Beth Officer A-Award A Stock Option (Right to Buy) 162,162 7.36 1.19M 162,162 D
2026-01-08 McCulloch Kevin Officer S-Sale D Common Stock 15,000 8.00 120.0K 1,685,426 D
2026-01-05 Shannon John Patrick Jr Director / Officer M-Exempt D Stock Option (Right to Buy) 25,136 1.55 39.0K 0 D
2026-01-02 Hecht Beth Officer S-Sale D Common Stock 16,667 7.43 123.8K 1,308,103 D
2025-12-19 JOHNSON JOHN Director S-Sale D Common Stock 135,400 7.22 977.0K 698,083 D
2025-12-12 BORMANN-KENNEDY BARBARA-JEAN ANNE Director S-Sale D Common Stock 15,000 7.09 106.4K 142,500 D
2025-12-01 Hecht Beth Officer S-Sale D Common Stock 16,667 7.01 116.8K 1,320,176 D
2025-11-14 Shannon John Patrick Jr Director / Officer M-Exempt A Common Stock 87,100 1.55 135.0K 2,730,253 D
2025-11-13 Shannon John Patrick Jr Director / Officer M-Exempt D Stock Option (Right to Buy) 8,970 1.55 13.9K 151,365 D
2025-11-11 Hecht Beth Officer S-Sale D Common Stock 16,667 7.40 123.3K 1,336,843 D
2025-10-02 McCulloch Kevin Officer F-InKind D Common Stock 733 8.31 6.1K 1,700,426 D
2025-09-11 PERSKY MARLA Director S-Sale D Common Stock 15,500 7.72 119.6K 142,000 D
2025-09-11 McCulloch Kevin Officer J-Other D Common Stock 2,000 0.00 0 I
2025-08-28 SHERMAN JEFFREY W Director M-Exempt A Common Stock 47,040 6.66 313.3K 261,420 D
2025-08-13 JOHNSON JOHN Director S-Sale D Common Stock 107,500 7.32 786.5K 833,483 D
2025-08-12 HALKUFF DAWN Director S-Sale D Common Stock 42,500 7.28 309.2K 115,000 D
2025-08-01 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 36,918 5.38 198.6K 2,657,425 D
2025-08-01 McCulloch Kevin Officer F-InKind D Common Stock 14,651 5.38 78.8K 1,701,159 D
2025-06-13 McCulloch Kevin Officer P-Purchase A Common Stock 25,000 4.38 109.5K 1,708,585 D
2025-06-04 SHERMAN JEFFREY W Director A-Award A Common Stock 50,000 0.00 214,380 D
2025-06-04 PERSKY MARLA Director A-Award A Common Stock 50,000 0.00 157,500 D
2025-06-04 Kong Garheng Director A-Award A Common Stock 50,000 0.00 214,144 D
2025-06-04 JOHNSON JOHN Director A-Award A Common Stock 50,000 0.00 940,983 D
2025-06-04 HALKUFF DAWN Director A-Award A Common Stock 50,000 0.00 157,500 D
2025-06-04 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Common Stock 50,000 0.00 157,500 D
2025-04-02 McCulloch Kevin Officer F-InKind D Common Stock 733 5.15 3.8K 1,683,585 D
2025-03-28 Brady James Aloysius Director 0 0.00 0
2025-03-20 Hecht Beth Officer S-Sale D Common Stock 40,000 5.43 217.2K 1,353,510 D
2025-02-25 Nguyen Anh Tu Officer Stock Appreciation Right 150,000 3.76 564.0K 0 D
2025-01-31 Shannon John Patrick Jr Director / Officer A-Award A Stock Appreciation Right 600,000 3.56 2.14M 600,000 D
2025-01-31 Pieper Steven Officer A-Award A Stock Appreciation Right 300,000 3.56 1.07M 300,000 D
2025-01-31 McCulloch Kevin Officer A-Award A Stock Appreciation Right 500,000 3.56 1.78M 500,000 D
2025-01-31 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 25,842 3.56 92.0K 320,446 D
2025-01-31 Hecht Beth Officer F-InKind D Common Stock 45,909 3.56 163.4K 1,306,885 D
2025-01-03 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 39,443 3.61 142.4K 2,108,618 D
2025-01-03 Pieper Steven Officer F-InKind D Common Stock 32,059 3.61 115.7K 1,409,761 D
2025-01-03 McCulloch Kevin Officer F-InKind D Common Stock 24,501 3.61 88.4K 1,577,452 D
2025-01-03 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 12,401 3.61 44.8K 361,764 D
2025-01-03 Hecht Beth Officer F-InKind D Common Stock 32,039 3.61 115.7K 1,352,794 D
2024-11-22 Pieper Steven Officer M-Exempt A Common Stock 19,483 1.55 30.2K 1,441,820 D
2024-08-12 Schmid John P. Director P-Purchase A Common Stock 4,515 2.25 10.1K 25,200
2024-08-09 Schmid John P. Director P-Purchase A Common Stock 4,285 2.37 10.1K 20,685
2024-08-01 Shannon John Patrick Jr Director / Officer A-Award A Stock Appreciation Right 300,000 2.43 729.0K 300,000
2024-08-01 McCulloch Kevin Officer D Stock Option (Right to Buy) 80,000 3.94 315.2K 0
2024-07-28 Pieper Steven Officer F-InKind D Common Stock 14,767 2.61 38.5K 1,422,337
2024-06-05 Schmid John P. Director A-Award A Common Stock 50,000 0.00 113,159
2024-06-05 SHERMAN JEFFREY W Director A-Award A Common Stock 50,000 0.00 164,380
2024-06-05 PERSKY MARLA Director A-Award A Common Stock 50,000 0.00 107,500
2024-06-05 Kong Garheng Director A-Award A Common Stock 50,000 0.00 164,144
2024-06-05 JOHNSON JOHN Director A-Award A Common Stock 50,000 0.00 890,983
2024-06-05 HALKUFF DAWN Director A-Award A Common Stock 50,000 0.00 107,500
2024-06-05 Fairley Ricki Louise Director A-Award A Common Stock 50,000 0.00 135,000
2024-06-05 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Common Stock 50,000 0.00 107,500
2024-05-10 Schmid John P. Director P-Purchase A Common Stock 5,400 1.91 10.3K 16,400
2024-03-18 JOHNSON JOHN Director M-Exempt A Common Stock 215,600 1.99 429.0K 751,412
2024-03-15 SHERMAN JEFFREY W Director J-Other A Common Stock 6,502 0.25 1.6K 114,380
2024-03-15 Kong Garheng Director J-Other A Common Stock 6,474 0.25 1.6K 114,144
2024-03-15 JOHNSON JOHN Director J-Other A Common Stock 89,571 0.25 22.4K 840,983
2024-03-14 Schmid John P. Director P-Purchase A Common Stock 4,500 2.16 9.7K 11,000
2024-01-31 Shannon John Patrick Jr Officer A-Award A Common Stock 750,000 0.00 2,158,575
2024-01-31 Pieper Steven Officer F-InKind D Common Stock 110,750 2.46 272.4K 1,437,104
2024-01-31 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 15,131 2.46 37.2K 373,036
2024-01-31 Hecht Beth Officer A-Award A Common Stock 750,000 0.00 1,554,968
2024-01-31 Edick Paul R Director / Officer A-Award A Common Stock 1,500,000 0.00 3,788,064
2024-01-29 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 22,150 2.66 58.9K 2,258,811
2024-01-29 Pieper Steven Officer F-InKind D Common Stock 4,379 2.66 11.6K 1,547,854
2024-01-29 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 10,747 2.66 28.6K 388,167
2024-01-29 Hecht Beth Officer F-InKind D Common Stock 19,675 2.66 52.3K 1,426,711
2024-01-03 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 40,834 2.24 91.5K 2,280,961
2024-01-03 Pieper Steven Officer F-InKind D Common Stock 23,067 2.24 51.7K 1,552,233
2024-01-03 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 12,400 2.24 27.8K 398,914
2024-01-03 Hecht Beth Officer F-InKind D Common Stock 33,488 2.24 75.0K 1,446,386
2023-11-27 SHERMAN JEFFREY W Director P-Purchase A Common Stock 5,400 1.87 10.1K 5,400
2023-11-20 Pieper Steven Officer P-Purchase A Common Stock 28,000 1.95 54.6K 1,176,912
2023-11-20 HALKUFF DAWN Director P-Purchase A Common Stock 5,410 1.84 10.0K 5,410
2023-11-17 Shannon John Patrick Jr Officer P-Purchase A Common Stock 30,769 1.64 50.4K 1,408,575
2023-11-16 Schmid John P. Director P-Purchase A Common Stock 6,500 1.51 9.8K 6,500
2023-11-14 PERSKY MARLA Director P-Purchase A Common Stock 6,370 1.58 10.1K 6,370
2023-08-09 Edick Paul R Director / Officer P-Purchase A Common Stock 10,000 2.38 23.8K 2,288,064
2023-07-28 Pieper Steven Officer F-InKind D Common Stock 10,200 2.53 25.8K 1,575,300
2023-06-07 Schmid John P. Director A-Award A Common Stock 42,500 0.00 63,159
2023-06-07 SHERMAN JEFFREY W Director A-Award A Common Stock 42,500 0.00 107,878
2023-06-07 PERSKY MARLA Director A-Award A Common Stock 42,500 0.00 57,500
2023-06-07 Kong Garheng Director A-Award A Common Stock 42,500 0.00 107,670
2023-06-07 JOHNSON JOHN Director A-Award A Common Stock 42,500 0.00 535,812
2023-06-07 HALKUFF DAWN Director A-Award A Common Stock 42,500 0.00 57,500
2023-06-07 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Common Stock 42,500 0.00 57,500
2023-03-27 Fairley Ricki Louise Director A-Award A Common Stock 85,000 0.00 85,000
2023-01-31 Shannon John Patrick Jr Officer A-Award A Common Stock 750,000 0.00 1,377,806
2023-01-31 Pieper Steven Officer A-Award A Common Stock 750,000 0.00 1,148,912
2023-01-31 PRESTRELSKI STEVEN Officer A-Award A Common Stock 150,000 0.00 719,780
2023-01-31 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 3,393 1.24 4.2K 411,314
2023-01-31 Hecht Beth Officer A-Award A Common Stock 350,000 0.00 797,758
2023-01-31 Edick Paul R Director / Officer A-Award A Common Stock 750,000 0.00 2,278,064
2023-01-29 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 23,414 1.26 29.5K 2,331,675
2023-01-29 Pieper Steven Officer F-InKind D Common Stock 3,590 1.26 4.5K 1,586,278
2023-01-29 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 11,029 1.26 13.9K 414,707
2023-01-29 Hecht Beth Officer F-InKind D Common Stock 21,177 1.26 26.7K 1,485,658
2023-01-03 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 41,334 1.12 46.3K 2,355,089
2023-01-03 Pieper Steven Officer F-InKind D Common Stock 23,067 1.12 25.8K 1,589,868
2023-01-03 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 12,400 1.12 13.9K 425,736
2023-01-03 Hecht Beth Officer F-InKind D Common Stock 33,488 1.12 37.5K 1,506,835
2022-12-13 Edick Paul R Officer P-Purchase A Common Stock 20,000 1.45 29.0K 1,528,064
2022-07-28 Pieper Steven Officer F-InKind D Common Stock 9,767 1.43 14.0K 1,612,935
2022-06-08 Schmid John P. Director A-Award A Common Stock 15,000 0.00 20,659
2022-06-08 SHERMAN JEFFREY W Director A-Award A Common Stock 15,000 0.00 65,378
2022-06-08 PERSKY MARLA Director A-Award A Stock Option (Right to Buy) 25,000 0.00 25,000
2022-06-08 Kong Garheng Director A-Award A Stock Option (Right to Buy) 25,000 2.10 52.5K 25,000
2022-06-08 JOHNSON JOHN Director A-Award A Common Stock 15,000 0.00 493,312
2022-06-08 HALKUFF DAWN Director A-Award A Common Stock 15,000 0.00 15,000
2022-06-08 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Stock Option (Right to Buy) 25,000 2.10 52.5K 25,000
2022-05-12 Edick Paul R Officer P-Purchase A Common Stock 100,000 1.40 140.4K 1,508,064
2022-02-22 PRESTRELSKI STEVEN Officer M-Exempt A Common Stock 11,228 0.69 7.7K 581,008
2022-01-31 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 7,497 2.11 15.8K 2,396,423
2022-01-31 Pieper Steven Officer F-InKind D Common Stock 750 2.11 1.6K 1,622,702
2022-01-31 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 2,307 2.11 4.9K 438,136
2022-01-31 Hecht Beth Officer F-InKind D Common Stock 4,448 2.11 9.4K 1,540,323
2022-01-29 Shannon John Patrick Jr Director / Officer F-InKind D Common Stock 15,692 2.11 33.1K 2,403,920
2022-01-29 Pieper Steven Officer F-InKind D Common Stock 3,460 2.11 7.3K 1,623,452
2022-01-29 JOHNSON KENNETH ERLAND Officer F-InKind D Common Stock 7,497 2.11 15.8K 440,443
2022-01-29 Hecht Beth Officer F-InKind D Common Stock 14,037 2.11 29.6K 1,544,771
2022-01-03 Shannon John Patrick Jr Officer A-Award A Common Stock 250,000 0.00 618,910
2022-01-03 Pieper Steven Officer A-Award A Common Stock 200,000 0.00 388,834
2022-01-03 PRESTRELSKI STEVEN Officer A-Award A Common Stock 75,000 0.00 569,780
2022-01-03 JOHNSON KENNETH ERLAND Officer A-Award A Common Stock 75,000 0.00 165,865
2022-01-03 Hecht Beth Officer A-Award A Common Stock 225,000 0.00 436,821
2022-01-03 Edick Paul R Director / Officer A-Award A Common Stock 600,000 0.00 1,408,064
2021-11-15 Edick Paul R Director / Officer P-Purchase A Common Stock 20,000 2.28 45.7K 33,430
2021-11-12 Shannon John Patrick Jr Officer P-Purchase A Common Stock 60,000 2.10 126.0K 363,829
2021-11-11 Shannon John Patrick Jr Officer P-Purchase A Common Stock 40,000 2.09 83.5K 303,829
2021-11-11 Edick Paul R Director / Officer P-Purchase A Common Stock 200,000 2.08 415.8K 808,064
2021-11-10 Pieper Steven Officer P-Purchase A Common Stock 25,000 2.00 49.9K 183,108
2021-10-05 Shannon John Patrick Jr Officer A-Award A Stock Option (Right to Buy) 160,335 1.55 248.5K 160,335
2021-10-05 Schmid John P. Director 0 0.00 0
2021-10-05 SHERMAN JEFFREY W Director 0 0.00 0
2021-10-05 Pieper Steven Officer D-Return D Stock Option (Right to Buy) 2,640 1.55 4.1K 0
2021-10-05 PRESTRELSKI STEVEN Officer A-Award A Stock Option (Right to Buy) 28,072 1.55 43.5K 28,072
2021-10-05 PERSKY MARLA Director A-Award A Stock Option (Right to Buy) 20,000 10.00 200.0K 20,000
2021-10-05 Kong Garheng Director A-Award A Common Stock 50,170 0.00 50,170
2021-10-05 JOHNSON KENNETH ERLAND Officer D-Return D Stock Option (Right to Buy) 39,633 5.93 235.0K 0
2021-10-05 JOHNSON JOHN Director A-Award A Stock Option (Right to Buy) 68,600 2.43 166.7K 68,600 D
2021-10-05 Hecht Beth Officer D-Return D Stock Option (Right to Buy) 150,000 3.94 591.0K 0
2021-10-05 HALKUFF DAWN Director A-Award A Stock Option (Right to Buy) 19,650 12.50 245.6K 19,650
2021-10-05 Edick Paul R Director / Officer A-Award A Stock Option (Right to Buy) 69,822 1.55 108.2K 69,822
2021-10-05 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-07-28 Pieper Steven Officer A-Award A Common Stock 100,000 0.00 158,858
2021-06-08 Schmid John P. Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-06-08 SHERMAN JEFFREY W Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-06-08 PERSKY MARLA Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-06-08 HALKUFF DAWN Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-06-08 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Stock Option (Right to Buy) 11,228 3.90 43.8K 11,228
2021-04-12 PRESTRELSKI STEVEN Officer S-Sale D Common Stock 10,000 4.07 40.7K 496,824
2021-01-29 Shannon John Patrick Jr Officer A-Award A Common Stock 150,000 0.00 271,224
2021-01-29 PRESTRELSKI STEVEN Officer A-Award A Common Stock 100,000 0.00 506,824
2021-01-29 JOHNSON KENNETH ERLAND Officer A-Award A Common Stock 65,000 0.00 91,890
2021-01-29 Hecht Beth Officer A-Award A Common Stock 150,000 0.00 210,814
2021-01-29 Edick Paul R Director / Officer A-Award A Stock Option (Right to Buy) 400,000 5.08 2.03M 400,000
2021-01-29 Deutsch Barry M. Officer A-Award A Common Stock 115,000 0.00 208,090
2021-01-13 PRESTRELSKI STEVEN Officer S-Sale D Common Stock 10,000 6.01 60.1K 406,824
2021-01-11 PRESTRELSKI STEVEN Officer S-Sale D Common Stock 10,000 5.72 57.2K 416,824
2020-12-16 PRESTRELSKI STEVEN Officer G-Gift D Common Stock 10,000 0.00 426,824
2020-12-09 Edick Paul R Director / Officer P-Purchase A Common Stock 10,000 4.06 40.6K 411,134
2020-08-18 Shannon John Patrick Jr Officer A-Award A Stock Option (right to buy) 100,000 4.29 429.0K 100,000
2020-08-14 PRESTRELSKI STEVEN Officer A-Award A Stock Option (Right to Buy) 25,000 4.19 104.8K 25,000
2020-08-14 JOHNSON KENNETH ERLAND Officer A-Award A Stock Option (Right to Buy) 100,000 4.19 419.0K 100,000
2020-08-14 Hecht Beth Officer A-Award A Stock Option (Right to Buy) 150,000 4.19 628.5K 150,000
2020-08-14 Deutsch Barry M. Officer A-Award A Stock Option (Right to Buy) 100,000 4.19 419.0K 100,000
2020-06-30 Shannon John Patrick Jr Officer A-Award A Common Stock 3,731 2.26 8.4K 121,224
2020-06-30 JOHNSON KENNETH ERLAND Officer A-Award A Common Stock 775 2.26 1.8K 26,890
2020-06-30 Hecht Beth Officer A-Award A Common Stock 3,731 2.26 8.4K 60,814
2020-06-30 Deutsch Barry M. Officer A-Award A Common Stock 3,731 2.26 8.4K 93,090
2020-06-04 Thierer Mark Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-06-04 Schmid John P. Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-06-04 SHERMAN JEFFREY W Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-06-04 PERSKY MARLA Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-06-04 HALKUFF DAWN Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-06-04 BORMANN-KENNEDY BARBARA-JEAN ANNE Director A-Award A Stock Option (right to buy) 11,228 4.68 52.5K 11,228
2020-05-13 Shannon John Patrick Jr Officer P-Purchase A Common Stock 22,000 3.55 78.0K 117,493
2020-05-08 Shannon John Patrick Jr Officer P-Purchase A Common Stock 7,886 3.20 25.2K 95,493
2020-05-08 Edick Paul R Director / Officer P-Purchase A Common Stock 33,000 3.00 99.0K 401,134
2020-03-13 Hecht Beth Officer P-Purchase A Common Stock 4,000 1.97 7.9K 57,083
2020-02-14 Shannon John Patrick Jr Officer P-Purchase A Common Stock 12,048 4.15 50.0K 22,607
2020-02-14 JOHNSON KENNETH ERLAND Officer P-Purchase A Common Stock 2,410 4.15 10.0K 6,115
2020-02-14 Hecht Beth Officer P-Purchase A Common Stock 4,000 4.15 16.6K 8,083

Executive team

Top executives
EBIT / Employee
1.4K
Shares Outstanding
172.43M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 John Shannon Chief Executive Officer 742.3K 2.85M 838.6K 608.0K 5.7K 5.04M 73.11%
2 2025 Kevin McCulloch President and Chief Operating Officer 543.8K 658.6K 698.8K 342.6K 27.1K 2.27M 59.77%
3 2025 Chief Medical Officer 409.2K 1.13M 218.9K 232.0K 12.4K 2.00M 67.33%
4 2025 Anh Nguyen 409.2K 1.13M 218.9K 232.0K 12.4K 2.00M 67.33%
5 2025 Beth P. Hecht Chief Legal Officer and Corporate Secretary 517.1K 658.6K 419.3K 293.2K 7.1K 1.90M 56.87%
6 2025 Steven M. Pieper Chief Financial Officer 505.4K 658.6K 419.3K 286.6K 4.2K 1.87M 57.52%
7 2024 Paul Edick Former Chief Executive Officer 421.4K 3.69M 539.0K 301.1K 1.88M 6.83M 61.95%
8 2024 John Shannon Chief Executive Officer 629.2K 2.45M 309.0K 433.5K 2.9K 3.83M 72.16%
9 2024 John Shannon Chief Executive Officer 629.2K 2.45M 309.0K 433.5K 2.9K 3.83M 72.16%
10 2024 Beth P. Hecht Chief Legal Officer and Corporate Secretary 491.7K 1.85M 267.7K 8.3K 2.61M 70.61%
11 2024 Beth P. Hecht Chief Legal Officer and Corporate Secretary 491.7K 1.85M 267.7K 8.3K 2.61M 70.61%
12 2024 Kevin McCulloch President and Chief Operating Officer 490.3K 1.59M 206.0K 281.2K 5.5K 2.58M 69.85%
13 2024 Kevin McCulloch President and Chief Operating Officer 490.3K 1.59M 206.0K 281.2K 5.5K 2.58M 69.85%
14 2024 Steven M. Pieper Chief Financial Officer 479.6K 1.11M 261.1K 6.3K 1.85M 59.71%
15 2024 Steven M. Pieper Chief Financial Officer 479.6K 1.11M 261.1K 6.3K 1.85M 59.71%
16 2024 Ken Johnson Senior Vice President, Global Development and Medical Affairs 414.1K 430.5K 182.2K 31.6K 1.06M 40.67%
17 2023 Paul Edick Former Chief Executive Officer 693.9K 930.0K 499.6K 13.2K 2.14M 43.52%
18 2023 Paul R. Edick Chief Executive Officer 693.9K 930.0K 499.6K 13.2K 2.14M 43.52%
19 2023 John P. Shannon President and Chief Operating Officer 571.4K 930.0K 343.9K 2.8K 1.85M 50.32%
20 2023 John Shannon Chief Executive Officer 571.4K 930.0K 343.9K 2.8K 1.85M 50.32%
21 2023 John Shannon Chief Executive Officer 571.4K 930.0K 343.9K 2.8K 1.85M 50.32%
22 2023 Steven M. Pieper Chief Financial Officer 436.0K 930.0K 232.0K 13.2K 1.61M 57.72%
23 2023 Steven M. Pieper Chief Financial Officer 436.0K 930.0K 232.0K 13.2K 1.61M 57.72%
24 2023 Beth P. Hecht Chief Legal Officer and Corporate Secretary 460.6K 434.0K 221.8K 13.0K 1.13M 38.43%
25 2023 Beth P. Hecht Chief Legal Officer and Corporate Secretary 460.6K 434.0K 221.8K 13.0K 1.13M 38.43%
26 2023 Ken Johnson Senior Vice President, Global Development and Medical Affairs 398.2K 124.0K 191.7K 7.1K 721.0K 17.20%
27 2022 Paul Edick Former Chief Executive Officer 691.7K 1.69M 416.4K 11.5K 2.81M 60.09%
28 2022 Paul R. Edick Chief Executive Officer 691.7K 1.69M 416.4K 11.5K 2.81M 60.09%
29 2022 Paul Edick, Chief Executive Officer 691.7K 1.69M 416.4K 11.5K 2.81M 60.09%
30 2022 John Shannon Chief Executive Officer 549.4K 702.5K 275.6K 2.7K 1.53M 45.91%
31 2022 John Shannon, President and Chief Operating Officer 549.4K 702.5K 275.6K 2.7K 1.53M 45.91%
32 2022 John P. Shannon President and Chief Operating Officer 549.4K 702.5K 275.6K 2.7K 1.53M 45.91%
33 2022 Beth Hecht, Chief Legal Officer and Corporate Secretary 442.2K 632.3K 177.7K 18.4K 1.27M 49.76%
34 2022 Beth P. Hecht Chief Legal Officer and Corporate Secretary 442.2K 632.3K 177.7K 18.4K 1.27M 49.76%
35 2021 Paul Edick, Chief Executive Officer 664.1K 1.14M 1.35M 598.5K 5.8K 3.76M 66.30%
36 2021 Paul R. Edick Chief Executive Officer 664.1K 1.14M 1.35M 598.5K 5.8K 3.76M 66.30%
37 2021 Barry Deutsch, Former Chief Financial Officer 318.8K 584.2K 169.2K 726.9K 1.80M 32.47%
38 2021 John P. Shannon President and Chief Operating Officer 527.5K 762.0K 396.2K 43.0K 1.73M 44.08%
39 2021 John Shannon, President and Chief Operating Officer 527.5K 762.0K 396.2K 43.0K 1.73M 44.08%
40 2021 Beth Hecht, Chief Legal Officer and Corporate Secretary 417.2K 762.0K 239.8K 6.1K 1.42M 53.47%
41 2021 Beth P. Hecht Chief Legal Officer and Corporate Secretary 417.2K 762.0K 239.8K 6.1K 1.42M 53.47%
42 2020 Paul Edick, Chief Executive Officer 627.0K 1.18M 453.2K 5.7K 2.26M 52.04%
43 2020 John Shannon, President and Chief Operating Officer 473.7K 414.1K 246.3K 300.0K 2.4K 1.44M 45.97%
44 2020 Beth Hecht, Chief Legal Officer and Corporate Secretary 392.9K 286.7K 369.5K 189.8K 5.6K 1.24M 52.72%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-23 DEFA14A
2026-04-23 DEF 14A
2025-04-23 DEFA14A
2025-04-23 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-07 8-K
2026-05-07 10-Q
2026-05-01 4
2026-04-23 DEFA14A
2026-04-23 DEF 14A
2026-04-23 ARS
2026-04-21 8-K
2026-04-03 4
2026-04-01 4
2026-03-27 SC 13G/A

Executive team

NameTitleCompensationGender
John Shannon Chief Executive Officer & Director 1M male
Kevin McCulloch President & Chief Operating Officer 913.5K male
Beth Hecht Chief Legal Officer & Corporate Secretary 817.4K female
Steven Pieper Chief Financial Officer 796.2K male
Anh Nguyen Chief Medical Officer 653.7K
Brian Conner SVP of Quality and Chief Compliance & Risk Officer male
Kendal Korte Senior Vice President of Human Resources female
Allison Wey Senior Vice President of Investor Relations & Corporate Communications female
ESG Rating
B
BIOTECHNOLOGY
2026
E (Environmental)
78.3 / 56.3
Company / Sector avg.
S (Social)
59.1 / 62.4
Company / Sector avg.
G (Governance)
70.3 / 60.9
Company / Sector avg.
ESG Total
69.2 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits